Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
20.06.25
/
50%
€32.00
Target price
20.06.26
€55.59
Performance (%)
-26.03%
End price
21.06.26
€23.67
Summary
This prediction ended on 21.06.26 with a price of €23.67. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -26.03%. Guggenheim has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -5.805% | -5.805% | 1.422% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
14.00%
08:32
08:32
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.10
08.05.26
08.05.26
€36.67
08.05.27
08.05.27
6.02%
08:32
08:32